Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 24% ± 4% | |
glutamatergic neuron | 3 studies | 18% ± 1% | |
hematopoietic precursor cell | 3 studies | 23% ± 5% | |
transit amplifying cell | 3 studies | 35% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 16% ± 0% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2943.82 | 1444 / 1445 | 100% | 109.89 | 183 / 183 |
ovary | 100% | 1819.81 | 180 / 180 | 100% | 86.98 | 429 / 430 |
stomach | 100% | 2125.56 | 359 / 359 | 99% | 71.98 | 284 / 286 |
uterus | 100% | 2763.10 | 170 / 170 | 99% | 86.97 | 455 / 459 |
intestine | 100% | 2831.77 | 966 / 966 | 99% | 70.13 | 522 / 527 |
lung | 100% | 2182.96 | 577 / 578 | 99% | 75.27 | 1145 / 1155 |
skin | 100% | 4937.31 | 1809 / 1809 | 99% | 69.92 | 467 / 472 |
breast | 100% | 2178.14 | 458 / 459 | 99% | 60.50 | 1105 / 1118 |
bladder | 100% | 2440.43 | 21 / 21 | 99% | 67.37 | 497 / 504 |
thymus | 100% | 2674.37 | 653 / 653 | 96% | 38.73 | 580 / 605 |
brain | 99% | 1346.43 | 2614 / 2642 | 97% | 38.48 | 682 / 705 |
prostate | 100% | 2351.61 | 245 / 245 | 92% | 24.09 | 463 / 502 |
pancreas | 96% | 1062.15 | 315 / 328 | 96% | 39.13 | 171 / 178 |
kidney | 99% | 1608.02 | 88 / 89 | 87% | 24.15 | 788 / 901 |
adrenal gland | 98% | 2050.25 | 253 / 258 | 70% | 17.33 | 160 / 230 |
liver | 91% | 744.66 | 205 / 226 | 45% | 13.26 | 182 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 85.27 | 29 / 29 |
spleen | 100% | 4153.07 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 114.45 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 20.96 | 1 / 1 |
blood vessel | 100% | 2344.86 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 1898.97 | 1203 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 5613.99 | 915 / 929 | 0% | 0 | 0 / 0 |
muscle | 98% | 1129.39 | 788 / 803 | 0% | 0 | 0 / 0 |
heart | 93% | 1066.89 | 799 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 24.98 | 74 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1905820 | Biological process | positive regulation of chromosome separation |
GO_0007076 | Biological process | mitotic chromosome condensation |
GO_1905821 | Biological process | positive regulation of chromosome condensation |
GO_0051301 | Biological process | cell division |
GO_0010032 | Biological process | meiotic chromosome condensation |
GO_0051984 | Biological process | positive regulation of chromosome segregation |
GO_0000228 | Cellular component | nuclear chromosome |
GO_0000796 | Cellular component | condensin complex |
GO_0000779 | Cellular component | condensed chromosome, centromeric region |
GO_0000794 | Cellular component | condensed nuclear chromosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0000793 | Cellular component | condensed chromosome |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0042393 | Molecular function | histone binding |
Gene name | NCAPD2 |
Protein name | NCAPD2 protein Condensin complex subunit 1 (Chromosome condensation-related SMC-associated protein 1) (Chromosome-associated protein D2) (hCAP-D2) (Non-SMC condensin I complex subunit D2) (XCAP-D2 homolog) Non-SMC condensin I complex subunit D2 |
Synonyms | CAPD2 CNAP1 KIAA0159 |
Description | FUNCTION: Regulatory subunit of the condensin complex, a complex required for conversion of interphase chromatin into mitotic-like condense chromosomes. The condensin complex probably introduces positive supercoils into relaxed DNA in the presence of type I topoisomerases and converts nicked DNA into positive knotted forms in the presence of type II topoisomerases. May target the condensin complex to DNA via its C-terminal domain . May promote the resolution of double-strand DNA catenanes (intertwines) between sister chromatids. Condensin-mediated compaction likely increases tension in catenated sister chromatids, providing directionality for type II topoisomerase-mediated strand exchanges toward chromatid decatenation. Required for decatenation of non-centromeric ultrafine DNA bridges during anaphase. Early in neurogenesis, may play an essential role to ensure accurate mitotic chromosome condensation in neuron stem cells, ultimately affecting neuron pool and cortex size . . |
Accessions | F5GZK7 ENST00000539084.5 A0PJ76 E7EN77 ENST00000382457.8 ENST00000539714.5 Q15021 ENST00000315579.10 F5H431 |